Folger Tuggle

Director, Medicaid Market Access & Public Policy at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Folger Tuggle's Colleagues at Alnylam Pharmaceuticals
Cristin Kaspar

Director Clinical Development

Contact Cristin Kaspar

Paul Mataruse

Thought Leader Liaison - West Region

Contact Paul Mataruse

Karin Van

Key Account Manager Belgium/Luxemburg

Contact Karin Van

View All Folger Tuggle's Colleagues
Folger Tuggle's Contact Details
HQ
(617) 551-8200
Location
Norwich, Vermont, United States
Company
Alnylam Pharmaceuticals
Folger Tuggle's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Folger Tuggle
Folger Tuggle currently works for Alnylam Pharmaceuticals.
Folger Tuggle's role at Alnylam Pharmaceuticals is Director, Medicaid Market Access & Public Policy.
Folger Tuggle's email address is ***@alnylam.com. To view Folger Tuggle's full email address, please signup to ConnectPlex.
Folger Tuggle works in the SaaS industry.
Folger Tuggle's colleagues at Alnylam Pharmaceuticals are Ahmed Quadri, Cristin Kaspar, Ahmed Quadri, Paul Mataruse, Karin Van, Neil Wallace, Joëlle Cabolet and others.
Folger Tuggle's phone number is (617) 551-8200
See more information about Folger Tuggle